By Lauren Neergaard

It’s been a month since a Maryland man became the second person to receive a transplanted heart from a pig –- and hospital video released Friday shows he’s working hard to recover.

Lawrence Faucette was dying from heart failure and ineligible for a traditional heart transplant because of other health problems when doctors at the University of Maryland School of Medicine offered the highly experimental surgery.

In the first glimpse of Faucette provided since the Sept. 20 transplant, hospital video shows physical therapist Chris Wells urging him to smile while pushing through a pedaling exercise to regain his strength.

“That’s going to be tough but I’ll work it out,” Faucette, 58, replied, breathing heavily but giving a smile.

The Maryland team last year performed the world’s first transplant of a heart from a genetically altered pig into another dying man. David Bennett survived just two months before that heart failed, for reasons that aren’t completely clear although signs of a pig virus later were found inside the organ. Lessons from that first experiment led to changes before this second try, including better virus testing.

Attempts at animal-to-human organ transplants — called xenotransplants — have failed for decades, as people’s immune systems immediately destroyed the foreign tissue. Now scientists are trying again using pigs genetically modified to make their organs more humanlike.

In Friday’s hospital video, Faucette’s doctors said the pig heart has shown no sign of rejection.

“His heart is doing everything on its own,” said Dr. Muhammad Mohiuddin, the Maryland team’s cardiac xenotransplantation chief.

A hospital spokeswoman said Faucette, of Frederick, Maryland, has been able to stand and physical therapists are helping him gain strength needed to attempt walking.

Many scientists hope xenotransplants one day could compensate for the huge shortage of human organ donations. More than 100,000 people are on the nation’s list for a transplant, most awaiting kidneys, and thousands will die waiting.

A handful of scientific teams have tested pig kidneys and hearts in monkeys and in donated human bodies, hoping to learn enough for the Food and Drug Administration to allow formal xenotransplant studies.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Share:
More In Science
Billionaire Businessman Jared Isaacman Set to Return to Space with Polaris Program
Space travel is growing rapidly, and one billionaire businessman has purchased three SpaceX flights in order to push the industry forward. The Polaris Dawn, the first of three flights, will launch later this year, and its crew will conduct the first commercial spacewalk after they've reached the highest orbit in over 50 years. Jared Isaacman, Polaris Program Mission Commander and Founder & CEO of Shift4, joins Closing Bell to discuss the Polaris program's mission, when the first launch will happen and what it will entail, balancing his business with space exploration efforts, charitable efforts with St. Jude Children's Research Hospital, and more.
U.S. Surpasses 200 Gigawatts of Total Clean Power Capacity
The most recent quarterly report from American Clean Power reveals the U.S. surpassed more than 200 gigawatts of total operating utility-scale clean power capacity in 2021. While it is a great milestone, significant policy issues have continued to slow growth for the industry and threaten our country's ability to meet emissions goals. John Hensley, VP for Research and Analytics at American Clean Power, joined Cheddar News to discuss more.
Social Beverage Brand Cann Raises $27 Million to Fuel International Expansion
Cann, a cannabis-infused beverage company, announced today a $27 million Series A funding round from existing investors like Imaginary Ventures and a roster of new celebrity investors including Nina Dobrev, Adam Devine, Zoey Deutch, Jordan Cooper, Sara Foster, and Rosario Dawson. Cann is also announcing its first international expansion with the brand's launch in Canada. Jake Bullock, co-founder and CEO of Cann, joins Cheddar News' Closing Bell to discuss.
Federal Govt. Pledges Billions on Nuclear Power Plants
By 2050, nuclear power share of total energy consumption will dip to just 3.7% down from the already measly 4.5% it is today, according to the U. S. Energy Information Administration. However, a group of world powers including the U.S. and Japan is looking to reverse the trend. John Kotek, SVP of Policy Development and Public Affairs at the Nuclear Energy Institute, joined Cheddar News to discuss.
Equip Raises $58 Million Series B Funding to Revolutionize Treatment of Eating Disorders
Equip is a virtual treatment platform for eating disorders, and recently raised $58 million in a Series B round led by The Chernin Group. The company aims to revolutionize treatment for eating disorders by delivering virtual care teams and clinical expertise directly to families' homes. Equip says the need for its platform has only been exacerbated by the COVID-19 pandemic. The National Eating Disorder Association's helpline has had a 107% increase in contacts since the start of the pandemic. Kristina Saffran, CEO and co-founder of Equip, joins Cheddar News' Closing Bell to discuss.
Load More